191 related articles for article (PubMed ID: 24091803)
1. Stability-Indicating Spectrofluorimetric Methods for the Determination of Metolazone and Xipamide in Their Tablets. Application to Content Uniformity Testing.
Walash MI; El-Enany N; Eid MI; Fathy ME
J Fluoresc; 2014 Mar; 24(2):363-76. PubMed ID: 24091803
[TBL] [Abstract][Full Text] [Related]
2. Stability-indicating spectrofluorimetric method for determination of itopride hydrochloride in raw material and pharmaceutical formulations.
Walash MI; Ibrahim F; Eid MI; El Abass SA
J Fluoresc; 2013 Nov; 23(6):1293-300. PubMed ID: 23852162
[TBL] [Abstract][Full Text] [Related]
3. Micelle-enhanced spectrofluorimetric determination of amlexanox in bioadhesive buccal tablets: application to content uniformity testing.
Walash MI; Belal F; Tolba MM; Halawa MI
Luminescence; 2015 Sep; 30(6):823-9. PubMed ID: 25611457
[TBL] [Abstract][Full Text] [Related]
4. Stability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules.
Walash MI; Belal F; El-Enany N; Eid M; El-Shaheny RN
J Fluoresc; 2011 Jul; 21(4):1659-67. PubMed ID: 21327537
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of metolazone and losartan in their combined tablets using synchronous fluorescence spectroscopy.
Fathy ME; El-Awady MI; Belal F
Luminescence; 2019 Sep; 34(6):607-614. PubMed ID: 31111664
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of Two Robust Stability-Indicating Chromatographic Methods for Determination of Metolazone in Drug Substance and Pharmaceutical Dosage Form in the Presence of Its Degradation Products and Characterization of Main Degradation Products Based on LC-MS.
Zaazaa HE; Abdel-Ghany R; Abdelkawy M; Sayed M
J Chromatogr Sci; 2020 Apr; 58(3):251-261. PubMed ID: 31879759
[TBL] [Abstract][Full Text] [Related]
7. Validated stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of repaglinide in tablets.
El-Shaheny RN
J Fluoresc; 2012 Nov; 22(6):1587-94. PubMed ID: 22752435
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.
Mohamed AI; Omar MA; Hammad MA; Mohamed AA
J Fluoresc; 2016 Nov; 26(6):2141-2149. PubMed ID: 27566613
[TBL] [Abstract][Full Text] [Related]
9. Stability-indicating HPLC method for determination of naftazone in tablets. Application to degradation kinetics and content uniformity testing.
Walash MI; Belal F; El-Enany N; Eid M; El-Shaheny RN
J Chromatogr Sci; 2011 Aug; 49(7):495-501. PubMed ID: 21801479
[TBL] [Abstract][Full Text] [Related]
10. Micelle-enhanced spectrofluorimetric method for determination of lacidipine in tablet form; application to content uniformity testing.
Belal F; Sharaf El-Din M; Tolba MM; Alaa H
Luminescence; 2015 Sep; 30(6):805-11. PubMed ID: 25504545
[TBL] [Abstract][Full Text] [Related]
11. Micelle-enhanced spectrofluorimetric method for determination of cyproheptadine hydrochloride in tablets: application to in-vitro drug release and content uniformity test.
Belal F; El-Din MK; Tolba MM; Elmansi H
J Fluoresc; 2014 Jan; 24(1):85-91. PubMed ID: 23900846
[TBL] [Abstract][Full Text] [Related]
12. An eco-friendly stability-indicating spectrofluorimetric method for the determination of two anticancer stereoisomer drugs in their pharmaceutical preparations following micellar enhancement: Application to kinetic degradation studies.
El-Kimary EI; El-Yazbi AF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jun; 163():145-53. PubMed ID: 27045788
[TBL] [Abstract][Full Text] [Related]
13. Stability-indicating micelle-enhanced spectrofluorimetric method for determination of loratadine and desloratadine in dosage forms.
Walash MI; Belal F; El-Enany N; Eid M; El-Shaheny RN
Luminescence; 2011; 26(6):670-9. PubMed ID: 21491578
[TBL] [Abstract][Full Text] [Related]
14. Micelle-enhanced direct spectrofluorimetric method for the determination of linifanib: Application to stability studies.
Zawaneh AH; Khalil NN; Ibrahim SA; Al-Dafiri WN; Maher HM
Luminescence; 2017 Nov; 32(7):1162-1168. PubMed ID: 28378538
[TBL] [Abstract][Full Text] [Related]
15. Spectrofluorimetric analysis of gemifloxacin mesylate in pharmaceutical formulations.
Al-Tamimi SA; Alarfaj NA; Aly FA; Al-Mohaimeed AM
Luminescence; 2014 Mar; 29(2):127-31. PubMed ID: 23681953
[TBL] [Abstract][Full Text] [Related]
16. Micelle-enhanced spectrofluorimetric method for determination of cholesterol-reducing drug ezetimibe in dosage forms.
Alarfaj NA; Aly FA
J Fluoresc; 2012 Jan; 22(1):9-15. PubMed ID: 21858740
[TBL] [Abstract][Full Text] [Related]
17. Spectrofluorimetric determination of amisulpride and bumidazone in raw materials and tablets.
Walash MI; Belal F; Tolba MM; Halawa MI
Luminescence; 2014 Dec; 29(8):1202-5. PubMed ID: 24723476
[TBL] [Abstract][Full Text] [Related]
18. Validated spectrofluorimetric and spectrophotometric methods for the determination of brimonidine tartrate in ophthalmic solutions via derivatization with NBD-Cl. Application to stability study.
Ibrahim F; El-Enany N; El-Shaheny RN; Mikhail IE
Luminescence; 2015 May; 30(3):309-17. PubMed ID: 25044105
[TBL] [Abstract][Full Text] [Related]
19. Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).
Walsh M; Belal F; El-Enany N; Elmansi H
J Fluoresc; 2011 Jan; 21(1):105-12. PubMed ID: 20593227
[TBL] [Abstract][Full Text] [Related]
20. Selective Spectrofluorimetric Method with Enhanced Sensitivity for Determination of Silodosine in Dosage Form and Human Plasma. Application to Stability Studies and Content Uniformity Testing.
Omar MA; Mohamed AI; Derayea SM; Hammad MA; Mohamed AA
J Fluoresc; 2017 Mar; 27(2):473-482. PubMed ID: 27864702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
